Harbor Healthcare mergers & acquisitions, is pleased to announce the successful sale of two behavioral health pharmacies located in California. The pharmacies, which include a closed-door long-term care (LTC) pharmacy and a retail pharmacy, primarily serve patients with mental health and substance use disorders. The acquisition was made by a private equity-backed strategic pharmacy operator […]
In my 2023 Market Outlook Report I wrote about how marginalized patient populations and economic inflation can impact pharmacy values. Since publishing that article, Harbor Healthcare closed one of the largest behavioral health pharmacy transactions in the United States. Subsequently, the firm completed and is in the process of completing, several more behavioral health pharmacy […]
Nevada – Harbor Healthcare Consultants proudly announces the successful sale of a specialized behavioral health focused long-term care pharmacy with multiple locations throughout the state. Acting as the Exclusive Sell-Side Advisor, Harbor Healthcare facilitated this strategic acquisition by a private equity-backed company, marking their first and meaningful expansion into Nevada’s behavioral health sector. This transaction […]
Harbor Healthcare Consultants, a leading mergers and acquisitions advisory firm specializing in pharmacy transactions, is pleased to announce the successful sale of one of IV Services to Genefic, a premier provider of comprehensive infusion and specialty pharmacy services. The transaction represents a strategic move for both parties. IV Services, a respected provider of infusion therapies, […]
Harbor Healthcare Consultants, a leading pharmacy mergers and acquisitions advisory firm founded by pharmacist Ira Cammeyer, is pleased to announce the successful sale of a premier 503A compounding pharmacy accredited for sterile and non-sterile formulations. Licensed in 12 states across the mid-Atlantic, The Compounding Center, originally established in 1976, built an exceptional reputation for quality […]
Southern California | 2024 Harbor Healthcare Consultants is pleased to announce the successful sale of a premier specialty infusion pharmacy and home healthcare business, headquartered in Southern California, to a leading nationwide pharmacy services company. Harbor Healthcare Consultants served as the exclusive sell-side advisor for the transaction. The seller, a well-respected pharmacy provider has established […]
Eastern USA • April 2024 Harbor Healthcare Consultants, a leading healthcare advisory firm, is pleased to announce the successful completion of the acquisition of a dual-location long-term care (“LTC”) pharmacy focused on behavioral health by a leading private equity-backed strategic acquirer. The acquisition, facilitated by Harbor Healthcare, spans operations across two eastern US states and […]
Los Angeles, CA – 2024 – American Integrative Pharmacy, a distinguished 503A Compounding Pharmacy based in Los Angeles, California, and specializing in mental health, hormones, and women’s health, officially announced its acquisition by a nationwide pharmacy. The strategic purchase further accelerates the acquirer’s continued growth and expansion in the 503A compounding industry. Harbor Healthcare Consultants […]
California, 2023 – Harbor Healthcare Consultants, a leading M&A advisory firm specializing in healthcare and pharmacy transactions, proudly announces the successful sale of California’s largest independent behavioral health pharmacy services company, to a leading Private Equity acquirer with extensive experience and expertise in the healthcare space. This milestone transaction reflects the culmination of strategic efforts […]
This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader economy created challenges for transactions and Semaglutide created a boom for sellers. but pause for buyers. However, as the year progressed, anxiety dissipated, and buyers resumed their acquisition mandates. Last but not least, the constant […]